AVIK DUTTA

About

I earned my B.S. and M.S. degrees in Biochemistry from the University of Calcutta, India, and received a Ph.D. from SUNY Upstate Medical University, USA. I have completed post-doctoral research at the University of Virginia, USA. Currently, I am a visiting postdoctoral Fellow at NICHD, NIH, USA. Skilled in Flow Cytometry, Confocal Imaging, Mouse Handling, Real-Time Polymerase Chain Reaction (qPCR), Microsoft Word, SDS-PAGE, Public Speaking, and Molecular Biology.

Employment

• National Institute of Allergy and Infectious Diseases Research Fellow
  2026 - Present
• Children's National Staff Scientist
  2025 - 2026
• National Institute of Child Health and Human Development Postdoctoral Research Fellow
  2020 - 2025
• University of Virginia Health System Postdoctoral Research Associate
  2019 - 2020

Education

• SUNY Upstate Medical University PhD
  2012 - 2018
• University of Calcutta Department of Biochemistry M.Sc
  2009 - 2011
• University of Calcutta B.Sc
  2006 - 2009

Projects & Funding

Projects & funding information is unavailable.

Publications (24)

• THEMIS: new insights into its evolution, structure, and function
  Trends in Immunology 2026 DOI: 10.1016/J.IT.2026.02.006
  +Save
• SRSF2 mutation reduces polycythemia and impairs hematopoietic progenitor functions in JAK2V617F-driven myeloproliferative neoplasm
  Blood Cancer Journal 2023 DOI: 10.1038/s41408-023-00947-y
  +Save
• GRB2 promotes thymocyte positive selection by facilitating THEMIS-mediated inactivation of SHP1
  Journal of Experimental Medicine 2023 DOI: 10.1084/jem.20221649
  +Save
• THEMIS increases TCR signaling in CD4 + CD8 + thymocytes by inhibiting the activity of the tyrosine phosphatase SHP1
  Science Signaling 2023 DOI: 10.1126/scisignal.ade1274
  +Save
• Genetic Deletion or Pharmacologic Inhibition of PTPN11 Impedes the Development and Progression of Myeloproliferative Neoplasms Induced By JAK2V617F and MPLW515L Mutants
  Blood 2023 DOI: 10.1182/BLOOD-2023-190216
  +Save
• Interleukin-1 contributes to clonal expansion and progression of bone marrow fibrosis in JAK2V617F-induced myeloproliferative neoplasm
  Nature Communications 2022 DOI: 10.1038/s41467-022-32928-3
  +Save
• Epigenetic Regulations of T Cell Differentiation
  2022
  +Save
• Genetic ablation of Pim1 or pharmacologic inhibition with TP-3654 ameliorates myelofibrosis in murine models
  Leukemia 2022 DOI: 10.1038/s41375-021-01464-2
  +Save
• IL-1 Signaling Promotes Clonal Expansion and Progression of Bone Marrow Fibrosis in JAK2V617F-Induced Myeloproliferative Neoplasm
  Blood 2021 DOI: 10.1182/BLOOD-2021-147517
  +Save
• U2af1 is required for survival and function of hematopoietic stem/progenitor cells
  Leukemia 2021 DOI: 10.1038/s41375-020-01116-x
  +Save